UK to Establish World’s First AI Biosecurity Lab With £300 Million Backing From Government, OpenAI and Anthropic
The U.K. is establishing the world’s first dedicated AI biosecurity organisation, bringing frontier artificial intelligence and biological science together to detect biological threats earlier and accelerate vaccines, treatments and other medical countermeasures.
The AI Biosecurity Lab (AIBL) will receive £100 million ($133.7 million) in government funding, alongside up to £200 million ($267.49 million) in commitments from OpenAI and Anthropic, as the U.K. moves to strengthen defences against biological risks emerging alongside increasingly capable AI.
The initiative comes as advances in AI create new opportunities for scientific discovery while also changing the biological risk landscape.
The U.K. Government said: “AI can accelerate research, improve our understanding of diseases, and support the discovery and development of new medical countermeasures. However, increasingly capable AI systems also create new biological risks and could lower barriers to harmful activity.”
AI Lab Targets Earlier Detection Of Biological Threats
AIBL will focus initially on developing technical capabilities to enhance early detection of emerging biological threats and accelerate the development of vaccines, treatments and other medical countermeasures.
The lab will bring together frontier AI and biological science talent to improve the U.K.‘s ability to understand, prevent, detect and respond to biological threats. It will work with the U.K.’s national biosecurity centres and life sciences industry to translate AI advances into practical capabilities.
The government said AIBL will “strengthen our biosecurity by harnessing frontier AI,” with its research intended to improve resilience against a wide range of biological risks, including risks enabled by advances in AI.
The lab will also be designed to help the U.K. and other countries respond faster to disease outbreaks while strengthening resilience against future biological threats.
OpenAI, Anthropic Commit Up To £200 Million
The private-sector backing will give AIBL access to frontier AI capabilities from some of the world’s leading AI companies. OpenAI will provide £100 million in compute and model credits and trusted access to its most capable relevant models through its Rosalind Biodefense programme.
Anthropic will provide up to £100 million in model credits, trusted model access and dedicated technical support.
AIBL will additionally work with Google DeepMind and U.K. AI life sciences company Basecamp Research. Basecamp Research will provide access to its AI-biology models, capabilities and technical expertise, while Google DeepMind scientists and biosecurity experts will collaborate with AIBL and look to provide trusted access to frontier Gemini and specialised science models.
Independent Lab To Link AI, Health And National Security
AIBL will operate as an independent, non-profit organisation, with the government aiming to establish the U.K. as a world leader in AI-enabled biosecurity. Its structure is intended to attract leading industry and academic talent while giving the organisation sufficient autonomy to operate with the speed and focus of a frontier AI-biotechnology company.
The lab will work within a broader National AI Biosecurity Initiative, bringing together the U.K. Health Security Agency, Animal and Plant Health Agency, Defence Science and Technology Laboratory and life sciences sector.
AIBL will also work with the Medicines and Healthcare products Regulatory Agency to prepare for health emergencies and inform regulation of AI-designed medicines.
The government said partnerships will be central to AIBL, with public-sector organisations, universities, industry and frontier AI companies expected to contribute to research and biosecurity capabilities. The initiative is also intended to attract public and philanthropic funding over time, expanding investment in the U.K.’s ability to anticipate and respond to biological threats.
